India has aggressively forced international pharmas to offer exceptionally low domestic pricing ... if they refuse, the alternative is that the Indian governmen

India has aggressively forced international pharmas to offer exceptionally low domestic pricing ... if they refuse, the alternative is that the Indian government authorizes generics, regardless of the patent status of the commercial drug. India also has a "last mile" problem with medical care. It's still too common for villagers to slip through the cracks and not receive regular diagnosis or treatment.